Cervical cancer is the fourth largest for both incidence and mortality in females due to lack of proper diagnosis in early stages of cancer. Therefore, identification of serum biomarkers could help in earlier diagnosis and chances to improve the survival of cervical cancer patients. In this regard, we studied the levels of circulating p53 protein in cancer patients’ serum during the radiation therapy which is widely used method to treat cervical cancer. p53 is a tumor suppressor protein and is associated with genetic changes of the cell. It has a vital role in cell cycle and apoptosis during cell mutations. We examined the relationship between the levels of circulating p53 protein and radiotherapy. Our hypothesis was to prove p53 protein as a biomarker for clinical response to radiotherapy of cervical cancer patients’. Five cervical cancer patients’ were enrolled for the study and blood samples were collected from them before, during and after the radiation treatment. Post-radiotherapy, patients’ clinical response to radiotherapy was determined from the expression of p53 protein using Western blot method. For all the samples, the elevation of p53 protein was not observed in serum. As a preliminary study our results revealed that there was no correlation between serum levels of p53 protein and radiotherapy clinical response, as no band was observed on the transfer membrane after blotting.
P53 protein Cervical cancer Radiation response Biomarker Western blot
This is a preview of subscription content, log in to check access.
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68(6):394–424. https://doi.org/10.3322/caac.21492Google Scholar
Linzer DI, Levine AJ (1979) Characterization of a 54 K Dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells. Cell 17(1):43–52CrossRefGoogle Scholar
Lane DP (1984) Cell immortalization and transformation by the p53 gene. Nature 312(5995):596CrossRefGoogle Scholar
McBride OW, Merry D, Givol D (1986) The gene for human p 53 cellular tumor antigen is located on chromosome 17 short arm (17p13). Proc Nat Acad Sci 83(1):130–134. PMID: 3001719CrossRefGoogle Scholar